Aguado Brian A, Caffe Jordan R, Nanavati Dhaval, Rao Shreyas S, Bushnell Grace G, Azarin Samira M, Shea Lonnie D
Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA; Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA.
Proteomics Core Facility, Northwestern University, Chicago, IL 60611, USA.
Acta Biomater. 2016 Mar;33:13-24. doi: 10.1016/j.actbio.2016.01.043. Epub 2016 Feb 1.
Metastatic tumor cells colonize the pre-metastatic niche, which is a complex microenvironment consisting partially of extracellular matrix (ECM) proteins. We sought to identify and validate novel contributors to tumor cell colonization using ECM-coated poly(ε-caprolactone) (PCL) scaffolds as mimics of the pre-metastatic niche. Utilizing orthotopic breast cancer mouse models, fibronectin and collagen IV-coated scaffolds implanted in the subcutaneous space captured colonizing tumor cells, showing a greater than 2-fold increase in tumor cell accumulation at the implant site compared to uncoated scaffolds. As a strategy to identify additional ECM colonization contributors, decellularized matrix (DCM) from lungs and livers containing metastatic tumors were characterized. In vitro, metastatic cell adhesion was increased on DCM coatings from diseased organs relative to healthy DCM. Furthermore, in vivo implantations of diseased DCM-coated scaffolds had increased tumor cell colonization relative to healthy DCM coatings. Mass-spectrometry proteomics was performed on healthy and diseased DCM to identify candidates associated with colonization. Myeloperoxidase was identified as abundantly present in diseased organs and validated as a contributor to colonization using myeloperoxidase-coated scaffold implants. This work identified novel ECM proteins associated with colonization using decellularization and proteomics techniques and validated candidates using a scaffold to mimic the pre-metastatic niche.
The pre-metastatic niche consists partially of ECM proteins that promote metastatic cell colonization to a target organ. We present a biomaterials-based approach to mimic this niche and identify ECM mediators of colonization. Using murine breast cancer models, we implanted microporous PCL scaffolds to recruit colonizing tumor cells in vivo. As a strategy to modulate colonization, we coated scaffolds with various ECM proteins, including decellularized lung and liver matrix from tumor-bearing mice. After characterizing the organ matrices using proteomics, myeloperoxidase was identified as an ECM protein contributing to colonization and validated using our scaffold. Our scaffold provides a platform to identify novel contributors to colonization and allows for the capture of colonizing tumor cells for a variety of downstream clinical applications.
转移性肿瘤细胞在转移前生态位中定植,转移前生态位是一种复杂的微环境,部分由细胞外基质(ECM)蛋白组成。我们试图使用包被ECM的聚(ε-己内酯)(PCL)支架作为转移前生态位的模拟物来鉴定和验证肿瘤细胞定植的新因素。利用原位乳腺癌小鼠模型,植入皮下空间的纤连蛋白和IV型胶原包被的支架捕获了定植的肿瘤细胞,与未包被的支架相比,植入部位的肿瘤细胞积累增加了两倍以上。作为鉴定其他ECM定植因素的策略,对含有转移性肿瘤的肺和肝的脱细胞基质(DCM)进行了表征。在体外,相对于健康的DCM,患病器官的DCM涂层上转移性细胞的粘附增加。此外,与健康的DCM涂层相比,患病DCM包被的支架的体内植入增加了肿瘤细胞的定植。对健康和患病的DCM进行了质谱蛋白质组学分析,以鉴定与定植相关的候选物。髓过氧化物酶被鉴定为在患病器官中大量存在,并通过髓过氧化物酶包被的支架植入物验证其为定植的一个因素。这项工作使用脱细胞化和蛋白质组学技术鉴定了与定植相关的新型ECM蛋白,并使用支架模拟转移前生态位验证了候选物。
转移前生态位部分由促进转移性细胞向靶器官定植的ECM蛋白组成。我们提出了一种基于生物材料的方法来模拟这个生态位并鉴定定植的ECM介质。使用小鼠乳腺癌模型,我们植入微孔PCL支架以在体内募集定植的肿瘤细胞。作为调节定植的策略,我们用各种ECM蛋白包被支架,包括来自荷瘤小鼠的脱细胞肺和肝基质。在使用蛋白质组学对器官基质进行表征后髓过氧化物酶被鉴定为一种有助于定植的ECM蛋白,并使用我们的支架进行了验证。我们的支架提供了一个平台,以鉴定定植的新因素,并允许捕获定植的肿瘤细胞用于各种下游临床应用。